Study protocol for a multicenter non-inferiority randomized controlled trial to assess functional outcomes and cost-effectiveness of a primarily non-operative treatment strategy with cast immobilization versus immediate operative treatment followed by cast immobilization for patients with complete ulnar collateral ligament ruptures, including Stener lesions: MUSCAT study

Louise de Haas,Bastiaan van Hoorn,Veronique van de Lücht,N. Schep,M. Dijkgraaf,M. van Heijl,MUSCAT Trial Collaborator group,J. Debeij,B. Derksen,A. Greeven,M. Engelen,J. de Jong,C. van Laarhoven,A. Lenderink,A. Leijdesdorff,M. Leliveld,M. Leszczynksi,R. Liebrand,B. Meesters,A. Ottenhof,C. Pesch,K. Reisinger,J. Reinders,D.S Salentijn,T. Saltzherr,S. Stougie,A. Tan,L. de Vries,R. van Veen,D. Van der Velde,G. van der Bij,F. van der Pluijm,R. van Vugt,B. Weitenberg,P. Wittich,O. Wijers,W. Willems,Y. den Ouden,H. Zwaving
DOI: https://doi.org/10.1186/s13063-024-08576-x
IF: 2.728
2024-10-30
Trials
Abstract:Guidelines recommend operative treatment followed by cast immobilization for acute complete ulnar collateral ligament (UCL) ruptures, including Stener lesions. This recommendation is based on expert opinion, anatomic theories, and low-quality observational case series. High-quality studies comparing non-operative treatment to operative treatment are lacking. We hypothesize that primarily non-operative treatment with cast immobilization (cast immobilization) is non-inferior regarding functional outcome and carries concomitant lower costs compared with immediate operative treatment followed by cast immobilization (operative treatment) for complete UCL ruptures, including Stener lesions.
medicine, research & experimental
What problem does this paper attempt to address?